AARTIDRUGS
572.4
2019-01-04
AARTI DRUGS LTD.
Profitability metrics STANDALONE CONSOLIDATED
Asset Turnover 0.8676 0.8962
Current ratio 1.94 1.93
WC days 107.68 104.26
EBITDA (%) 16.14 16.25
FCF (Rs Cr.) 0 0
ROCE (%) 15.49 16.2
ROE (%) 16.9 18.06

Solvency metrics STANDALONE CONSOLIDATED
Cash Ratio 0.01 0.01
Div. payout (%) 3.21 2.87
Int. Coverage 4.08 4.26
LT D/E 1.2 1.2
Solvency Ratio 0.21 0.22

Valuation STANDALONE CONSOLIDATED
Beta 1.0428 1.0428
Div. yield (%) 0 0
EV (Rs Cr.) 1707.77 1736.41
P/BV 2.77 2.63
P/E 16.37 14.57
PEG 1.33 0.9
P/S 1.05 0.96

Balance sheet metrics STANDALONE CONSOLIDATED
BV/share 183.21 192.54
3Y growth BV/s (%) 46 51
Cash (Rs Cr.) 3.91 4.27
Total Debt (Rs Cr.) 517 546
Net block (Rs Cr.) 563 602

P&L metrics STANDALONE CONSOLIDATED
DPS 0.99 1
EPS 30.96 34.78
Net Income (Rs Cr.) 73 82
Operating profit (Rs Cr.) 185 202
No. of o/s shares 2.358 2.358
Revenue (Rs Cr.) 1140 1243
Total Income (Rs Cr.) 1141 1244

Cash Flow metrics STANDALONE CONSOLIDATED
CEPS (%) 2587 2926
3Y growth CEPS -0.41 -0.32
CFF (Rs Cr.) 9 3
CFI (Rs Cr.) -71 -73
CFO (Rs Cr.) 61 69
FCF (Rs Cr.) 0 0
3Y growth Op. CF (%) -43 -34

Growth metrics STANDALONE CONSOLIDATED
3Y growth dividends (%) -92 -92
1Q growth EBITDA (%) 0 0
3Y growth EBITDA (%) 6 17
4Q growth EBITDA (%) 0 0
1Q growth EPS (%) 0 0
3Y growth EPS (%) -3 9
4Q growth EPS (%) 0 0
3Y growth Net inc. (%) -6 6
1Y growth Op. CF (%) -65 -60
1Q growth revenue (%) 0 0
3Y growth revenue (%) 5 13
4Q growth revenue (%) 0 0